INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 18 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $546,371 | +270.3% | 550,500 | +265.8% | 0.00% | – |
| Q4 2022 | $147,553 | +0.4% | 150,500 | 0.0% | 0.00% | – |
| Q3 2022 | $147,000 | -0.7% | 150,500 | 0.0% | 0.00% | – |
| Q2 2022 | $148,000 | +1.4% | 150,500 | -2.0% | 0.00% | – |
| Q1 2022 | $146,000 | -27.7% | 153,500 | -7.3% | 0.00% | – |
| Q4 2021 | $202,000 | +46.4% | 165,500 | +7.8% | 0.00% | – |
| Q3 2021 | $138,000 | +0.7% | 153,500 | 0.0% | 0.00% | – |
| Q2 2021 | $137,000 | +10.5% | 153,500 | 0.0% | 0.00% | – |
| Q1 2021 | $124,000 | -47.0% | 153,500 | -49.6% | 0.00% | – |
| Q4 2020 | $234,000 | -70.0% | 304,500 | -68.6% | 0.00% | – |
| Q3 2020 | $780,000 | +2.0% | 970,500 | -4.4% | 0.00% | – |
| Q2 2020 | $765,000 | -8.2% | 1,015,000 | -2.6% | 0.00% | – |
| Q1 2020 | $833,000 | -24.5% | 1,042,000 | -4.8% | 0.00% | – |
| Q4 2019 | $1,103,000 | +13.9% | 1,094,000 | -2.8% | 0.00% | – |
| Q3 2019 | $968,000 | -7.2% | 1,126,000 | -3.8% | 0.00% | – |
| Q2 2019 | $1,043,000 | -61.4% | 1,170,000 | -57.2% | 0.00% | -100.0% |
| Q1 2019 | $2,705,000 | +153.0% | 2,734,000 | +135.7% | 0.00% | – |
| Q4 2018 | $1,069,000 | -11.4% | 1,160,000 | -2.8% | 0.00% | – |
| Q3 2018 | $1,206,000 | +8.2% | 1,193,000 | -6.2% | 0.00% | – |
| Q2 2018 | $1,115,000 | +9.0% | 1,272,000 | -0.3% | 0.00% | – |
| Q1 2018 | $1,023,000 | +26.6% | 1,276,000 | +25.6% | 0.00% | – |
| Q4 2017 | $808,000 | -1.9% | 1,016,000 | -4.8% | 0.00% | – |
| Q3 2017 | $824,000 | -41.3% | 1,067,000 | -26.0% | 0.00% | – |
| Q2 2017 | $1,403,000 | +3.3% | 1,442,000 | -1.0% | 0.00% | – |
| Q1 2017 | $1,358,000 | -63.5% | 1,457,000 | -65.1% | 0.00% | -100.0% |
| Q4 2016 | $3,717,000 | +88.5% | 4,170,000 | +136.4% | 0.00% | 0.0% |
| Q3 2016 | $1,972,000 | – | 1,764,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|